# Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overall-survival-with-osimertinib-in-untreated-i-egfr-i-mutated-advanced-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Suresh S. Ramalingam,Johan Vansteenkiste,David Planchard,Byoung Chul Cho,Jhanelle E. Gray,Yuichiro Ohe,Caicun Zhou,Thanyanan Reungwetwattana,Ying Cheng,Busyamas Chewaskulyong,Riyaz Shah,Manuel Cobo,Ki Hyeong Lee,Parneet Cheema,Marcello Tiseo,Thomas John,Meng‐Chih Lin,Fumio Imamura,Takayasu Kurata,Alexander Todd,Rachel Hodge,Matilde Saggese,Yuri Rukazenkov,Jean‐Charles Soria |
| Citations | 2,875 |
| DOI | 10.1056/nejmoa1913662 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1913662?articleTools=true |
| OpenAlex ID | https://openalex.org/W2990041408 |
| PMID | 31751012 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Jhanelle E. Gray](https://scholariq.org/researchers/jhanelle-e-gray/)
- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.